P04 Kategorie · weitere Spezifizierung erforderlich Newborn affected by noxious substances transmitted via placenta or breast milk
ICD-10-CM P04 identifies “Newborn affected by noxious substances transmitted via placenta or breast milk” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Kapitel 16: Certain conditions originating in the perinatal period
Hinweise zum Code
Includes1
nonteratogenic effects of substances transmitted via placenta
Excludes 24
- congenital malformations (Q00-Q99)
- encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-)
- neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4)
- newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-)
Code first1
any current condition in newborn, if applicable
Hinweise übergeordneter Ebenen
Kapitel 16 · Certain conditions originating in the perinatal period (P00-P96)
Includes1
conditions that have their origin in the fetal or perinatal period (before birth through the first 28 days after birth) even if morbidity occurs later
Excludes 25
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- tetanus neonatorum (A33)
Note1
Codes from this chapter are for use on newborn records only, never on maternal records
P00-P04 · Newborn affected by maternal factors and by complications of pregnancy, labor, and delivery (P00-P04)
Note1
These codes are for use when the listed maternal conditions are specified as the cause of confirmed morbidity or potential morbidity which have their origin in the perinatal period (before birth through the first 28 days after birth).
Spezifischere Codes
P04.0Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and deliveryAbrechenbarer, spezifischer CodeP04.1Newborn affected by other maternal medicationKategorie · weitere Spezifizierung erforderlichP04.2Newborn affected by maternal use of tobaccoAbrechenbarer, spezifischer CodeP04.3Newborn affected by maternal use of alcoholAbrechenbarer, spezifischer CodeP04.4Newborn affected by maternal use of drugs of addictionKategorie · weitere Spezifizierung erforderlichP04.5Newborn affected by maternal use of nutritional chemical substancesAbrechenbarer, spezifischer CodeP04.6Newborn affected by maternal exposure to environmental chemical substancesAbrechenbarer, spezifischer CodeP04.8Newborn affected by other maternal noxious substancesKategorie · weitere Spezifizierung erforderlichP04.9Newborn affected by maternal noxious substance, unspecifiedAbrechenbarer, spezifischer CodeVerweise im offiziellen Index
Verweise anderer Codes (13)
Excludes 2 · newborn affected by noxious substances transmitted via placenta or breast milk (P04.-)
Excludes 2 · nonteratogenic effects of substances transmitted via placenta or breast milk (P04.-)
Excludes 2 · newborn affected by noxious substances transmitted via placenta or breast milk (P04.-)
Excludes 2 · certain conditions originating in the perinatal period (P04-P96)
Excludes 2 · certain conditions originating in the perinatal period (P04-P96)
Excludes 2 · certain conditions originating in the perinatal period (P04-P96)
Excludes 2 · certain conditions originating in the perinatal period (P04-P96)
Excludes 2 · certain conditions originating in the perinatal period (P04-P96)
Excludes 2 · certain conditions originating in the perinatal period (P04-P96)
Excludes 2 · certain conditions originating in the perinatal period (P04-P96)
Excludes 2 · certain conditions originating in the perinatal period (P04-P96)
Excludes 2 · certain conditions originating in the perinatal period (P04-P96)
Excludes 2 · certain conditions originating in the perinatal period (P04-P96)
Verlauf
Codeverlauf
Letzte erfasste Änderung · FY2022
Gültig ab
- Codehinweise geändert
Newborn affected by noxious substances transmitted via placenta or breast milk
Kategorie — spezifischeren Code auswählen
CDC/NCHS · FY2022Alle Ausgaben (19)
| Alle Ausgaben | Gültig ab | Codeverlauf |
|---|---|---|
| FY2016 | 2015-10-01 | Erstmals erfasst |
| FY2017 | 2016-10-01 | Bezeichnung geändert · Codehinweise geändert · Übergeordnete Hinweise geändert |
| FY2018 | 2017-10-01 | Keine tabellarische Änderung |
| FY2019 | 2018-10-01 | Keine tabellarische Änderung |
| FY2020 | 2019-10-01 | Keine tabellarische Änderung |
| FY2020 · April | 2020-04-01 | Keine tabellarische Änderung |
| FY2021 | 2020-10-01 | Keine tabellarische Änderung |
| FY2021 · 01-01 | 2021-01-01 | Keine tabellarische Änderung |
| FY2022 | 2021-10-01 | Codehinweise geändert |
| FY2022 · 04-01 | 2022-04-01 | Keine tabellarische Änderung |
| FY2023 | 2022-10-01 | Keine tabellarische Änderung |
| FY2023 · 04-01 | 2023-04-01 | Keine tabellarische Änderung |
| FY2024 | 2023-10-01 | Keine tabellarische Änderung |
| FY2024 · 04-01 | 2024-04-01 | Keine tabellarische Änderung |
| FY2025 | 2024-10-01 | Keine tabellarische Änderung |
| FY2025 · 04-01 | 2025-04-01 | Keine tabellarische Änderung |
| FY2026 | 2025-10-01 | Keine tabellarische Änderung |
| FY2026 · April | 2026-04-01 | Keine tabellarische Änderung |
| FY2027 | 2026-10-01 | Keine tabellarische Änderung |
Entdecken Sie die spezifischeren Codes dieser Kategorie. Die Referenzprüfung bestätigt keine klinische Eignung und garantiert keine Erstattung.